Published in Medical Devices and Surgical Technology Week, August 13th, 2006
MetaCore's technology platform's capacity to integrate multiple data types including proteomics and chemogenomics data was valued by Siena Biotech together with the quality of content in neurological diseases.
Georg C. Terstappen, vice president, discovery research, of the Siena Biotech, said, "GeneGo and Siena Biotech in their respective fields are the way in pathway proteomics. We expect advantages for both companies form this collaboration."
Julie Bryant, vice...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.